Product Information

RUFINAMIDE 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.4532 per EA under NDC 31722059912. Its NADAC has been published 253 times since Oct 20, 2021.

FDA first approved this application on May 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RUFINAMIDE 400 MG TABLET

Rufinamide
$1.4532per EA

Strength

400 mg/1

NDC

31722059912

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RUFINAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204993

FDA Approved

5/11/2021

TE Code

AB

On Market Since

5/11/2021

Price Statistics

The NADAC for RUFINAMIDE 400 MG TABLET has been published 253 times since Oct 20, 2021, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4532 per EA
All-time high$5.9562 (Jan 12, 2022)
All-time low$1.3608 (May 20, 2026)
52-week high$1.7050
52-week low$1.3608
Median price$3.5684
Average price$3.3710
Largest weekly change-38.3% (May 22, 2024)
Weeks tracked253
Tracking sinceOct 20, 2021

Price History

1W

+2.9%

1M

+2.9%

3M

+6.8%

6M

-9.5%

1Y

-5.2%

3Y

-64.3%

5Y

N/A

All

-75.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of RUFINAMIDE 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.4532 per EA (NDC 31722059912), effective Aug 19, 2026.

How has the price of RUFINAMIDE 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for RUFINAMIDE 400 MG TABLET has declined 75.6%. It has been tracked across 253 weekly CMS publications since Oct 20, 2021.

What are the highest and lowest recorded NADAC prices for RUFINAMIDE 400 MG TABLET?

Since Oct 20, 2021, the NADAC for RUFINAMIDE 400 MG TABLET has ranged from a low of $1.3608 (May 20, 2026) to a high of $5.9562 (Jan 12, 2022), with a median of $3.5684 per EA.

Are there cheaper alternatives to RUFINAMIDE 400 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RUFINAMIDE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RUFINAMIDE 400 MG TABLET?

RUFINAMIDE 400 MG TABLET (NDC 31722059912) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.